A cost-utility analysis of cochlear implants for single sided deafness in adults and children in the Netherlands
Based on the results of this health economic evaluation with a Markov cohort model, it is very likely that CI is cost-effective compared to BCD and to no treatment in the Dutch adult and pediatric population with SSD. In both populations the ICER was below the Dutch cost-effectiveness threshold of €20,000/QALY.
Authors
- Chris van Lieshout (ORCID: https://orcid.org/0000-0002-2870-9439)
- Adriana Leni Smit (ORCID: https://orcid.org/0000-0001-9126-9969)
- K. Abraham
- Geert Frederix
Institutions
- Utrecht University (NL)
- University Medical Center Utrecht (NL)
Publication Details
- Journal
- PLoS ONE
- Published
- 2024-08-05
- DOI
- https://doi.org/10.1371/journal.pone.0307881
- Citations
- 4
- Primary Topic
- Hearing Loss and Rehabilitation
- Type
- article
- Field-Weighted Citation Impact
- 1.37